MétaCan
Menu
Back to cohort
Record W4405035424 · doi:10.1182/blood-2024-198579

From Theory to Therapy: Evaluating Canadian Hemophilia Treatment Centres' Readiness for Gene Therapy Implementation

2024· article· en· W4405035424 on OpenAlexaffabout
Roy Khalifé, Lindsay Cowley, Alan Tinmouth, Lisa Duffett, Vanessa Bourck, Alfonso Iorio, Davide Matino, Kay Decker, Karen Strike, David Page, Natasha Pardy, Jerome Teitel, Haowei Sun

Bibliographic record

VenueBlood · 2024
Typearticle
Languageen
FieldMedicine
TopicBiomedical Ethics and Regulation
Canadian institutionsUniversity of AlbertaSt. Michael's HospitalUniversity of TorontoSt. John’s Health Sciences CentreCanadian Hemophilia SocietyHamilton Health SciencesMcMaster Children's HospitalMcMaster UniversityUniversity of OttawaThrombosis and Atherosclerosis Research InstituteImpactOttawa Hospital
Fundersnot available
KeywordsGenetic enhancementMedicineIntensive care medicineOncologyGeneBiologyGenetics

Abstract

fetched live from OpenAlex

Introduction: Gene therapies (GT) present a transformative promise for persons with hemophilia, potentially offering a long-term solution to improve patient care and experiences. However, in publicly funded systems, GT's promise will fall short if stakeholders' preparedness, capacity, and perceptions are not proactively examined to address barriers that might delay and limit its equitable access. Therefore, this study aims to examine healthcare professionals' (HCPs) perspectives on their readiness, motivation, and capacity to implement and use GT within Canadian Hemophilia Treatment Centres (HTCs). Methods: We conducted a cross-sectional online survey of HCPs across all Canadian HTCs, developed using the R=MC2 framework for organizational change. In this framework, organizational readiness is described as a function of the motivation and collective capacity to adopt and sustain an innovation, which in this context refers to hemophilia GT. We conducted cognitive pretesting and pilot testing to examine validity. We distributed the survey through each Canadian professional organizations involved in hemophilia care. Data were analyzed using descriptive statistics for quantitative data and coding into categories for qualitative data. Results: A total of 45 HCPs completed the survey from 80.1% (21/26) of Canadian HTCs, with a median experience in hemophilia care of 8 years (interquartile range [IQR] 5-15). Respondents included nurses/nurse practitioners (47.7%), physicians (37.8%), physiotherapists (8.9%), social workers (4.4%), and pharmacists (2.2%). All provinces were represented with the highest participation from Ontario (40%). Perceived Need, Benefits and Acceptance: Most respondents (76%) supported the integration of GT into the Canadian healthcare system, with a more favourable outlook for hemophilia B. Respondents identified a greater perceived need for GT in hemophilia B (76%) compared to hemophilia A (64%) and expressed higher confidence in the sufficiency of clinical evidence for hemophilia B GT (76%) versus hemophilia A (47%). Additionally, patient acceptance was perceived to be higher for hemophilia B given the current treatment landscape. Preparedness and Resources for GT Adoption: Despite their support, respondents raised concerns about HTCs' readiness, including insufficient human resources, patient education and support mechanisms, and clinical capacity for intensive post-GT monitoring. Only 20% felt their HTC had sufficient human resources, stressing needs for more nursing and psychosocial support. Respondents felt unprepared for GT implementation, highlighting low confidence in their HTC expertise and considerable educational gaps and needs, particularly from non-physicians. Careful Candidate Selection for GT: Suitable candidates were characterized by adherence to monitoring and treatment, minimal comorbidities specific to the risks of hepatotoxicity and/or corticosteroids related toxicities, and strong psychosocial stability or support system. Conversely, candidates with significant liver disease or metabolic health issues, poor adherence, psychological distress, and logistical barriers-such as difficulty in traveling to HTC or frequent clinic visits-were deemed less or not suitable. HTCs Coordination and Collaboration: Traditional hub-and-spoke models might not fit Canadian context. Varying opinions were noted regarding shared and individual responsibilities between HTCs. To enhance collaboration and workflow processes, respondents highlighted the need for national guidelines on patient selection, monitoring, and adverse event management. Establishing a national GT advisory group was supported by 67% of the 14 HTC directors, reflecting the need for centralized expertise and guidance. Conclusion: The successful integration of GT into hemophilia care in Canada requires addressing significant logistical, educational, and system-level barriers, enhancing support mechanisms and HTC resources, and ensuring careful candidate selection and coordination. Enhanced training for HCPs, clear clinical guidelines and protocols, and improved patient support mechanisms are essential to fully realize the potential of GT. Establishing a national GT advisory group and leveraging patient registries for long-term monitoring could facilitate the effective and equitable delivery of GT across Canada.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Other design · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.915
Threshold uncertainty score0.987

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.061
GPT teacher head0.397
Teacher spread0.336 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designOther design
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2024
Admission routes2
Has abstractyes

Explore more

Same venueBloodSame topicBiomedical Ethics and RegulationFrench-language works237,207